DocGo (DCGO) 21st Annual Needham Technology, Media, & Consumer Conference summary
Event summary combining transcript, slides, and related documents.
21st Annual Needham Technology, Media, & Consumer Conference summary
14 May, 2026Key business highlights
Focus on tech-driven mobile healthcare, expanding medical transportation, and care in the home, with a strong technology backbone integrated with Epic and athenahealth.
Medical transportation business generated over $200 million in revenue, with U.S. trip volume up 17% year-over-year in Q1.
Care in the home business grew 131% year-over-year, even excluding the SteadyMD acquisition, and patient monitoring serves 55,000 patients with 60% gross margins.
Virtual health platform completed over 1 million telehealth visits in Q1, operating in all 50 states with over 3,000 clinical staff and 900+ vehicles.
Patient net promoter score is 92, with strong partnerships with major hospital systems and insurers.
Financial performance and outlook
Q1 revenue was $75.5 million, with no COVID or migrant-related revenue for the first time in years.
Adjusted gross margin for the quarter was 31.6%, with an adjusted EBITDA loss of $10.2 million.
Raised full-year revenue guidance to $300–$315 million, with expected adjusted EBITDA loss of $5–$10 million and a path to profitability in the back half of the year.
No long-term debt and $60 million in cash on the balance sheet.
Growth in Q1 included 17% increase in U.S. medical transportation, 46% in healthcare in the home, and 37% in virtual care and lab orders.
Strategic initiatives and differentiation
Selected for CMS's ACCESS program, rewarding improved health outcomes and tech-supported care.
Recognized as one of the world's most ethical companies and best healthcare cyber company.
Proprietary tech platform enables efficient care delivery, leveraging AI for scheduling, billing, and clinical oversight.
Unique model combines in-person, virtual, and remote care, with a focus on closing care gaps and managing chronic conditions.
SteadyMD acquisition enhances telehealth capabilities and margin profile.
Latest events from DocGo
- Rapidly scaling mobile healthcare and transport with strong growth, tech integration, and expanding margins.DCGO
Investor presentation14 May 2026 - Q1 revenue was $75.6M, net loss widened, but 2026 guidance was raised on strong core growth.DCGO
Q1 202611 May 2026 - Key votes include director elections, reverse stock split, and auditor ratification for 2026.DCGO
Proxy filing23 Apr 2026 - Proxy seeks approval for director elections, reverse stock split, and key governance amendments.DCGO
Proxy filing22 Apr 2026 - Key proposals include director elections, a reverse stock split, and governance amendments.DCGO
Proxy filing10 Apr 2026 - 2026 guidance raised on core growth and SteadyMD gains, with H2 profitability targeted.DCGO
Q4 202516 Mar 2026 - Scaling tech-enabled mobile healthcare with record volumes and strong growth outlook.DCGO
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - All proposals passed, with strong financials and strategic growth initiatives outlined.DCGO
AGM 20243 Feb 2026 - Q2 revenue up 31% to $164.9M, net income and margins rose, and cash flow guidance increased.DCGO
Q2 20242 Feb 2026